Blue Owl Capital Holdings LP 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:05 pm Sale |
2024-09-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Blue Owl Capital Holdings LP | 515,855 1.920% |
-977,397 (-65.45%) |
Filing |
| 2024-02-14 8:56 pm Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Blue Owl Capital Holdings LP | 1,493,252 5.740% |
1,493,252 (New Position) |
Filing |